Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | TANGO THERAPEUTICS, INC. | $64,288,397 | – | 19,363,975 | – | 58.09% | – | |
| PLRX | New | PLIANT THERAPEUTICS, INC. | $38,647,550 | – | 2,132,867 | – | 34.92% | – |
| FULC | New | FULCRUM THERAPEUTICS, INC. | $7,732,408 | – | 2,343,154 | – | 6.99% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MGTA | Exit | MAGENTA THERAPEUTICS, INC. | $0 | – | -6,758,204 | – | -5.57% | – |
| FULC | Exit | FULCRUM THERAPEUTICS, INC. | $0 | – | -2,343,154 | – | -11.08% | – |
| RVMD | Exit | REVOLUTION MEDICINES, INC. | $0 | – | -1,419,900 | – | -16.36% | – |
| PLRX | Exit | PLIANT THERAPEUTICS, INC. | $0 | – | -2,132,867 | – | -26.04% | – |
| Exit | TANGO THERAPEUTICS, INC. | $0 | – | -19,363,975 | – | -40.96% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | TANGO THERAPEUTICS, INC. | $87,719,000 | – | 19,363,975 | – | 57.68% | – | |
| RVMD | New | REVOLUTION MEDICINES, INC. | $27,674,000 | – | 1,419,900 | – | 18.20% | – |
| PLRX | New | PLIANT THERAPEUTICS, INC. | $17,084,000 | – | 2,132,867 | – | 11.23% | – |
| FULC | New | FULCRUM THERAPEUTICS, INC. | $11,481,000 | – | 2,343,154 | – | 7.55% | – |
| MGTA | New | MAGENTA THERAPEUTICS, INC. | $8,110,000 | – | 6,758,204 | – | 5.33% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PLRX | Exit | PLIANT THERAPEUTICS, INC. | $0 | – | -2,132,867 | – | -8.17% | – |
| RVMD | Exit | REVOLUTION MEDICINES, INC. | $0 | – | -1,419,900 | – | -8.86% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS, INC. | $0 | – | -6,758,204 | – | -11.16% | – |
| FULC | Exit | FULCRUM THERAPEUTICS, INC. | $0 | – | -2,343,154 | – | -15.00% | – |
| Exit | TANGO THERAPEUTICS, INC. | $0 | – | -19,363,975 | – | -56.81% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | TANGO THERAPEUTICS, INC. | $250,376,000 | – | 19,363,975 | – | 56.81% | – | |
| MGTA | Sell | MAGENTA THERAPEUTICS, INC. | $49,200,000 | -37.2% | 6,758,204 | -15.6% | 11.16% | -70.1% |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MGTA | New | MAGENTA THERAPEUTICS, INC. | $78,320,000 | – | 8,008,204 | – | 37.29% | – |
| PLRX | New | PLIANT THERAPEUTICS, INC. | $62,109,000 | – | 2,132,867 | – | 29.57% | – |
| RVMD | New | REVOLUTION MEDICINES, INC. | $45,068,000 | – | 1,419,900 | – | 21.46% | – |
| FULC | New | FULCRUM THERAPEUTICS, INC. | $24,556,000 | – | 2,343,154 | – | 11.69% | – |
Q4 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FULC | Exit | FULCRUM THERAPEUTICS, INC. | $0 | – | -2,343,154 | – | -6.40% | – |
| PLRX | Exit | PLIANT THERAPEUTICS, INC. | $0 | – | -2,132,867 | – | -16.63% | – |
| RVMD | Exit | REVOLUTION MEDICINES, INC. | $0 | – | -1,419,900 | – | -17.01% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS, INC. | $0 | – | -8,008,204 | – | -18.75% | – |
| RLAY | Exit | RELAY THERAPEUTICS, INC. | $0 | – | -2,811,197 | – | -41.22% | – |
Q3 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RLAY | New | RELAY THERAPEUTICS, INC. | $119,729,000 | – | 2,811,197 | – | 41.22% | – |
Q2 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PLRX | New | PLIANT THERAPEUTICS, INC. | $69,233,000 | – | 2,132,867 | – | 31.90% | – |
| MGTA | New | MAGENTA THERAPEUTICS, INC. | $60,142,000 | – | 8,008,204 | – | 27.71% | – |
| RVMD | New | REVOLUTION MEDICINES, INC. | $44,826,000 | – | 1,419,900 | – | 20.65% | – |
| FULC | New | FULCRUM THERAPEUTICS, INC. | $42,856,000 | – | 2,343,154 | – | 19.74% | – |
Q4 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FULC | Exit | FULCRUM THERAPEUTICS, INC. | $0 | – | -2,343,154 | – | -15.92% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS, INC. | $0 | – | -8,008,204 | – | -84.08% | – |
Q3 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FULC | New | FULCRUM THERAPEUTICS, INC. | $15,559,000 | – | 2,343,154 | – | 15.92% | – |
Q2 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MGTA | New | MAGENTA THERAPEUTICS, INC. | $118,121,000 | – | 8,008,204 | – | 100.00% | – |